Drug Repurposing and Advanced Screening Techniques Training Course

Course Title: Drug Repurposing and Advanced Screening Techniques Training Course

Executive Summary

This two-week intensive course on Drug Repurposing and Advanced Screening Techniques provides participants with a comprehensive understanding of strategies to identify new uses for existing drugs and cutting-edge methods for high-throughput screening. The course covers target identification, assay development, data analysis, and validation techniques. Through lectures, case studies, and hands-on exercises, participants will learn how to accelerate drug discovery and development, reduce costs, and improve the efficiency of the drug development pipeline. The course equips participants with the knowledge and skills to contribute effectively to drug repurposing initiatives and implement advanced screening technologies in their research or organizations, ultimately impacting healthcare outcomes.

Introduction

Drug repurposing, also known as drug repositioning or drug rescue, is the identification of new uses for existing or abandoned drugs. This strategy offers a faster and more cost-effective route to drug discovery compared to developing novel drugs from scratch. Advanced screening techniques, including high-throughput screening (HTS) and phenotypic screening, play a crucial role in identifying potential drug repurposing candidates and accelerating the drug development process.This comprehensive training course is designed to provide participants with a thorough understanding of drug repurposing strategies and the application of advanced screening techniques. The course will cover various aspects of drug repurposing, including target identification, assay development, data analysis, and validation techniques. Participants will also learn about the latest advancements in high-throughput screening, including automation, miniaturization, and data analysis tools.The course is structured to provide a balance of theoretical knowledge and practical experience. Through lectures, case studies, and hands-on exercises, participants will develop the skills necessary to contribute effectively to drug repurposing initiatives and implement advanced screening technologies in their research or organizations. This course aims to empower professionals in the pharmaceutical, biotechnology, and academic sectors to leverage the potential of drug repurposing and advanced screening techniques to improve healthcare outcomes.

Course Outcomes

• Understand the principles and strategies of drug repurposing.
• Develop and optimize assays for high-throughput screening.
• Apply advanced screening techniques to identify potential drug repurposing candidates.
• Analyze and interpret high-throughput screening data.
• Validate drug repurposing candidates using in vitro and in vivo models.
• Design and implement drug repurposing studies.
• Apply advanced screening technologies in their research

Training Methodologies

• Interactive Lectures
• Case Study Analysis
• Hands-on Laboratory Exercises
• Group Discussions and Presentations
• Data Analysis Workshops
• Guest Lectures from Industry Experts
• Practical Simulations

Benefits to Participants

• Gain expertise in drug repurposing strategies.
• Develop skills in advanced screening techniques.
• Learn to analyze and interpret high-throughput screening data.
• Enhance ability to design and implement drug repurposing studies.
• Expand professional network with industry experts.
• Improve career prospects in the pharmaceutical and biotechnology sectors.
• Receive a certificate of completion.

Benefits to Sending Organization

• Accelerated drug discovery and development process.
• Reduced drug development costs.
• Improved efficiency of the drug development pipeline.
• Increased success rate of drug development programs.
• Enhanced reputation as an innovative organization.
• Development of internal expertise in drug repurposing and advanced screening.
• Increased potential for generating new intellectual property.

Target Participants

• Researchers in pharmaceutical companies
• Researchers in biotechnology companies
• Academics involved in drug discovery
• Postdoctoral fellows and graduate students
• Drug development professionals
• Screening scientists
• Bioinformaticians

WEEK 1: Foundations of Drug Repurposing and Screening

Module 1: Introduction to Drug Repurposing

1. Definition and history of drug repurposing
2. Advantages and disadvantages of drug repurposing
3. Regulatory pathways for repurposed drugs
4. Examples of successful drug repurposing stories
5. Ethical considerations in drug repurposing
6. Intellectual property issues in drug repurposing
7. Repurposing during pandemics and health crises

Module 2: Target Identification and Validation

1. Target identification strategies
2. Bioinformatics approaches for target identification
3. Experimental validation of targets
4. Protein-protein interaction networks
5. Gene expression profiling
6. Knockdown and knockout studies
7. Target validation in cellular and animal models

Module 3: Assay Development and Optimization

1. Assay development principles
2. Types of assays (biochemical, cell-based)
3. Selection of appropriate assay formats
4. Assay optimization techniques
5. High-throughput assay development
6. Quality control and validation of assays
7. Statistical analysis of assay data

Module 4: High-Throughput Screening (HTS) Technologies

1. Principles of high-throughput screening
2. Automation and miniaturization in HTS
3. Liquid handling systems
4. Plate readers and detection technologies
5. Compound libraries and management
6. HTS data management and analysis
7. Quality control in HTS

Module 5: Data Analysis and Interpretation

1. Statistical analysis of screening data
2. Hit identification and selection criteria
3. False positive and false negative rates
4. Data normalization and transformation
5. Dose-response curve analysis
6. Data visualization techniques
7. Data mining and machine learning approaches

WEEK 2: Advanced Screening Techniques and Implementation

Module 6: Phenotypic Screening

1. Principles of phenotypic screening
2. Advantages and disadvantages of phenotypic screening
3. Cell-based assays for phenotypic screening
4. Image-based screening
5. High-content screening (HCS)
6. Phenotypic data analysis and interpretation
7. Applications of phenotypic screening in drug repurposing

Module 7: In Silico Screening and Molecular Docking

1. Principles of in silico screening
2. Molecular docking techniques
3. Structure-based drug design
4. Ligand-based drug design
5. Virtual screening workflows
6. Scoring functions and validation
7. Applications of in silico screening in drug repurposing

Module 8: Validation and Lead Optimization

1. Validation of screening hits
2. Dose-response relationships
3. Cell viability assays
4. Mechanism of action studies
5. Lead optimization strategies
6. Structure-activity relationship (SAR) analysis
7. In vitro and in vivo studies

Module 9: Case Studies in Drug Repurposing

1. Case study 1: Sildenafil (Viagra) for pulmonary hypertension
2. Case study 2: Thalidomide for multiple myeloma
3. Case study 3: Minoxidil for hair loss
4. Case study 4: Metformin for cancer
5. Case study 5: Aspirin for cardiovascular disease prevention
6. Discussion of success factors and challenges
7. Future directions in drug repurposing

Module 10: Implementing Drug Repurposing Strategies

1. Developing a drug repurposing strategy
2. Building a drug repurposing team
3. Identifying potential drug repurposing candidates
4. Securing funding for drug repurposing projects
5. Navigating regulatory hurdles
6. Collaborating with industry partners
7. Commercializing repurposed drugs

Action Plan for Implementation

1. Identify a specific therapeutic area for drug repurposing.
2. Conduct a comprehensive literature review of existing drugs.
3. Identify potential drug-target interactions using bioinformatics tools.
4. Develop a high-throughput screening assay for the selected target.
5. Screen a library of existing drugs against the target.
6. Validate the hits using in vitro and in vivo models.
7. Develop a plan for clinical trials and regulatory approval.